Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  ACB | T.ACB.WS.U

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Post by davgroon Dec 07, 2022 12:39am
382 Views
Post# 35155208

UPDATE - SAFE Banking Act Removed from NDAA

UPDATE - SAFE Banking Act Removed from NDAA
By Jarrell Dillard, Bloomberg
December 6, 2022 at 9:46 p.m. EST

A marijuana banking measure was left out of a must-pass defense bill, significantly narrowing the chances that legislation to clear the way for legal cannabis businesses to use the financial system can get passed before Democrats lose control of the House in January.
 
A bipartisan group of senators had been negotiating to include a version of a bill known as the SAFE Banking Act in the annual National Defense Authorization Act, but the attempt ran into stiff opposition from Republican leaders.
 
The bill, introduced by Senators Jeff Merkley, an Oregon Democrat, and Steve Daines, a Montana Republican, would prohibit federal banking regulators from penalizing banks and other depository institutions for providing services to legal cannabis businesses.
 
Senate Republican leader Mitch McConnell on Tuesday expressed opposition to using the defense bill, enacted annually for more than 60 years, as a vehicle for a host of other priorities including “making our financial system more sympathetic to illegal drugs.”
 
This is the second failed attempt in months to get the measure approved in a larger package.
 
With time running out in this session of Congress the chances to pass the legislation are slim, though lawmakers could potentially attempt to attach the measure to a government funding package being debated.
 
<< Previous
Bullboard Posts
Next >>